ARTICLE | Clinical News
TM601: Phase I data
June 1, 2009 7:00 AM UTC
Data from 6 patients with recurrent glioblastoma in a Phase I trial showed that unlabeled TM601 was well tolerated, with intratumoral hemorrhage possibly related to treatment. TM601 reduced relative c...